Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
Type 1 diabetes (TID) is characterized by a loss of pancreatic islet beta cell function resulting in loss of insulin production. Genetic and environmental factors may trigger immune responses targeting beta cells thus generating islet antibodies (IA). Immune response pathways involve a cascade of ev...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5381877?pdf=render |
| _version_ | 1818136859281195008 |
|---|---|
| author | Kathleen Waugh Janet Snell-Bergeon Aaron Michels Fran Dong Andrea K Steck Brigitte I Frohnert Jill M Norris Marian Rewers |
| author_facet | Kathleen Waugh Janet Snell-Bergeon Aaron Michels Fran Dong Andrea K Steck Brigitte I Frohnert Jill M Norris Marian Rewers |
| author_sort | Kathleen Waugh |
| collection | DOAJ |
| description | Type 1 diabetes (TID) is characterized by a loss of pancreatic islet beta cell function resulting in loss of insulin production. Genetic and environmental factors may trigger immune responses targeting beta cells thus generating islet antibodies (IA). Immune response pathways involve a cascade of events, initiated by cytokines and chemokines, producing inflammation which can result in tissue damage.A nested case-control study was performed to identify temporal changes in cytokine levels in 75 DAISY subjects: 25 diagnosed T1D, 25 persistent IA, and 25 controls. Serum samples were selected at four time points: (T1) earliest, (T2) just prior to IA, (T3) just after IA, and (T4) prior to T1D diagnosis or most recent. Cytokines (IFN-α2a, IL-6, IL-17, IL-1β, IP-10, MCP-1, IFN-γ, IL-1α, and IL-1ra) were measured using the Meso Scale Discovery system Human Custom Cytokine 9-Plex assay.Multivariate mixed models adjusting for HLA risk, first-degree relative status, age, and gender, showed MCP-1 and IFN-үto be significantly higher at T3 in T1D compared to IA subjects. At T4, IP-10 was significantly higher in IA subjects than controls.This repeated measures nested case-control study identified increased inflammatory markers in IA children who developed T1D compared to IA children who had not progressed to clinical disease. It also showed increased inflammation in both T1D and IA children when compared to controls. Results suggest inflammation may be related to both the development of IA and progression to T1D. |
| first_indexed | 2024-12-11T09:47:06Z |
| format | Article |
| id | doaj.art-984f29cd1da54c8eacec803194b9aa16 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T09:47:06Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-984f29cd1da54c8eacec803194b9aa162022-12-22T01:12:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01124e017484010.1371/journal.pone.0174840Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).Kathleen WaughJanet Snell-BergeonAaron MichelsFran DongAndrea K SteckBrigitte I FrohnertJill M NorrisMarian RewersType 1 diabetes (TID) is characterized by a loss of pancreatic islet beta cell function resulting in loss of insulin production. Genetic and environmental factors may trigger immune responses targeting beta cells thus generating islet antibodies (IA). Immune response pathways involve a cascade of events, initiated by cytokines and chemokines, producing inflammation which can result in tissue damage.A nested case-control study was performed to identify temporal changes in cytokine levels in 75 DAISY subjects: 25 diagnosed T1D, 25 persistent IA, and 25 controls. Serum samples were selected at four time points: (T1) earliest, (T2) just prior to IA, (T3) just after IA, and (T4) prior to T1D diagnosis or most recent. Cytokines (IFN-α2a, IL-6, IL-17, IL-1β, IP-10, MCP-1, IFN-γ, IL-1α, and IL-1ra) were measured using the Meso Scale Discovery system Human Custom Cytokine 9-Plex assay.Multivariate mixed models adjusting for HLA risk, first-degree relative status, age, and gender, showed MCP-1 and IFN-үto be significantly higher at T3 in T1D compared to IA subjects. At T4, IP-10 was significantly higher in IA subjects than controls.This repeated measures nested case-control study identified increased inflammatory markers in IA children who developed T1D compared to IA children who had not progressed to clinical disease. It also showed increased inflammation in both T1D and IA children when compared to controls. Results suggest inflammation may be related to both the development of IA and progression to T1D.http://europepmc.org/articles/PMC5381877?pdf=render |
| spellingShingle | Kathleen Waugh Janet Snell-Bergeon Aaron Michels Fran Dong Andrea K Steck Brigitte I Frohnert Jill M Norris Marian Rewers Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). PLoS ONE |
| title | Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). |
| title_full | Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). |
| title_fullStr | Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). |
| title_full_unstemmed | Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). |
| title_short | Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). |
| title_sort | increased inflammation is associated with islet autoimmunity and type 1 diabetes in the diabetes autoimmunity study in the young daisy |
| url | http://europepmc.org/articles/PMC5381877?pdf=render |
| work_keys_str_mv | AT kathleenwaugh increasedinflammationisassociatedwithisletautoimmunityandtype1diabetesinthediabetesautoimmunitystudyintheyoungdaisy AT janetsnellbergeon increasedinflammationisassociatedwithisletautoimmunityandtype1diabetesinthediabetesautoimmunitystudyintheyoungdaisy AT aaronmichels increasedinflammationisassociatedwithisletautoimmunityandtype1diabetesinthediabetesautoimmunitystudyintheyoungdaisy AT frandong increasedinflammationisassociatedwithisletautoimmunityandtype1diabetesinthediabetesautoimmunitystudyintheyoungdaisy AT andreaksteck increasedinflammationisassociatedwithisletautoimmunityandtype1diabetesinthediabetesautoimmunitystudyintheyoungdaisy AT brigitteifrohnert increasedinflammationisassociatedwithisletautoimmunityandtype1diabetesinthediabetesautoimmunitystudyintheyoungdaisy AT jillmnorris increasedinflammationisassociatedwithisletautoimmunityandtype1diabetesinthediabetesautoimmunitystudyintheyoungdaisy AT marianrewers increasedinflammationisassociatedwithisletautoimmunityandtype1diabetesinthediabetesautoimmunitystudyintheyoungdaisy |